nodes	percent_of_prediction	percent_of_DWPC	metapath
Vildagliptin—DPP9—tendon—muscle cancer	0.144	0.191	CbGeAlD
Vildagliptin—DPP9—testis—muscle cancer	0.119	0.158	CbGeAlD
Vildagliptin—DPP4—embryo—muscle cancer	0.0934	0.124	CbGeAlD
Vildagliptin—DPP4—smooth muscle tissue—muscle cancer	0.0734	0.0974	CbGeAlD
Vildagliptin—DPP4—renal system—muscle cancer	0.0707	0.0937	CbGeAlD
Vildagliptin—DPP4—tendon—muscle cancer	0.0552	0.0732	CbGeAlD
Vildagliptin—DPP4—bone marrow—muscle cancer	0.0534	0.0709	CbGeAlD
Vildagliptin—DPP4—vagina—muscle cancer	0.0512	0.0679	CbGeAlD
Vildagliptin—DPP4—head—muscle cancer	0.0473	0.0627	CbGeAlD
Vildagliptin—DPP4—testis—muscle cancer	0.0457	0.0606	CbGeAlD
Vildagliptin—Skin exfoliation—Etoposide—muscle cancer	0.0069	0.028	CcSEcCtD
Vildagliptin—Liver function test abnormal—Dactinomycin—muscle cancer	0.00669	0.0272	CcSEcCtD
Vildagliptin—Blister—Doxorubicin—muscle cancer	0.0052	0.0211	CcSEcCtD
Vildagliptin—Hepatitis—Dactinomycin—muscle cancer	0.00501	0.0204	CcSEcCtD
Vildagliptin—Chills—Dactinomycin—muscle cancer	0.0045	0.0183	CcSEcCtD
Vildagliptin—Connective tissue disorder—Vincristine—muscle cancer	0.0044	0.0179	CcSEcCtD
Vildagliptin—Skin exfoliation—Methotrexate—muscle cancer	0.00413	0.0168	CcSEcCtD
Vildagliptin—Angiopathy—Vincristine—muscle cancer	0.00406	0.0165	CcSEcCtD
Vildagliptin—Infestation NOS—Etoposide—muscle cancer	0.00404	0.0164	CcSEcCtD
Vildagliptin—Infestation—Etoposide—muscle cancer	0.00404	0.0164	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Etoposide—muscle cancer	0.00382	0.0155	CcSEcCtD
Vildagliptin—Skin exfoliation—Doxorubicin—muscle cancer	0.00358	0.0145	CcSEcCtD
Vildagliptin—Oedema—Dactinomycin—muscle cancer	0.00356	0.0145	CcSEcCtD
Vildagliptin—Infection—Dactinomycin—muscle cancer	0.00354	0.0144	CcSEcCtD
Vildagliptin—Angiopathy—Etoposide—muscle cancer	0.00329	0.0134	CcSEcCtD
Vildagliptin—Chills—Etoposide—muscle cancer	0.00326	0.0132	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00324	0.0132	CcSEcCtD
Vildagliptin—Oedema—Vincristine—muscle cancer	0.00318	0.0129	CcSEcCtD
Vildagliptin—Infection—Vincristine—muscle cancer	0.00316	0.0129	CcSEcCtD
Vildagliptin—Nervous system disorder—Vincristine—muscle cancer	0.00312	0.0127	CcSEcCtD
Vildagliptin—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00311	0.0127	CcSEcCtD
Vildagliptin—Hyperhidrosis—Vincristine—muscle cancer	0.00308	0.0125	CcSEcCtD
Vildagliptin—Fatigue—Dactinomycin—muscle cancer	0.00307	0.0125	CcSEcCtD
Vildagliptin—Liver function test abnormal—Methotrexate—muscle cancer	0.0029	0.0118	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Vincristine—muscle cancer	0.0029	0.0118	CcSEcCtD
Vildagliptin—Dermatitis bullous—Doxorubicin—muscle cancer	0.00285	0.0116	CcSEcCtD
Vildagliptin—Hypoglycaemia—Doxorubicin—muscle cancer	0.00279	0.0113	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Vincristine—muscle cancer	0.00275	0.0112	CcSEcCtD
Vildagliptin—Fatigue—Vincristine—muscle cancer	0.00274	0.0112	CcSEcCtD
Vildagliptin—Constipation—Vincristine—muscle cancer	0.00272	0.0111	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00267	0.0109	CcSEcCtD
Vildagliptin—Pancreatitis—Methotrexate—muscle cancer	0.00266	0.0108	CcSEcCtD
Vildagliptin—Infection—Etoposide—muscle cancer	0.00256	0.0104	CcSEcCtD
Vildagliptin—Asthenia—Dactinomycin—muscle cancer	0.00256	0.0104	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00252	0.0103	CcSEcCtD
Vildagliptin—Liver function test abnormal—Doxorubicin—muscle cancer	0.00251	0.0102	CcSEcCtD
Vildagliptin—Skin disorder—Etoposide—muscle cancer	0.0025	0.0102	CcSEcCtD
Vildagliptin—Hyperhidrosis—Etoposide—muscle cancer	0.00249	0.0101	CcSEcCtD
Vildagliptin—Diarrhoea—Dactinomycin—muscle cancer	0.00244	0.00991	CcSEcCtD
Vildagliptin—Nasopharyngitis—Doxorubicin—muscle cancer	0.00243	0.00989	CcSEcCtD
Vildagliptin—Infestation NOS—Methotrexate—muscle cancer	0.00242	0.00984	CcSEcCtD
Vildagliptin—Infestation—Methotrexate—muscle cancer	0.00242	0.00984	CcSEcCtD
Vildagliptin—Pancreatitis—Doxorubicin—muscle cancer	0.00231	0.00937	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Methotrexate—muscle cancer	0.00229	0.00931	CcSEcCtD
Vildagliptin—Asthenia—Vincristine—muscle cancer	0.00228	0.00928	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Etoposide—muscle cancer	0.00223	0.00905	CcSEcCtD
Vildagliptin—Fatigue—Etoposide—muscle cancer	0.00222	0.00904	CcSEcCtD
Vildagliptin—Constipation—Etoposide—muscle cancer	0.0022	0.00896	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00219	0.00888	CcSEcCtD
Vildagliptin—Diarrhoea—Vincristine—muscle cancer	0.00218	0.00885	CcSEcCtD
Vildagliptin—Hepatitis—Methotrexate—muscle cancer	0.00217	0.00884	CcSEcCtD
Vildagliptin—Weight increased—Doxorubicin—muscle cancer	0.00214	0.0087	CcSEcCtD
Vildagliptin—Nausea—Dactinomycin—muscle cancer	0.00212	0.0086	CcSEcCtD
Vildagliptin—Dizziness—Vincristine—muscle cancer	0.0021	0.00856	CcSEcCtD
Vildagliptin—Infestation—Doxorubicin—muscle cancer	0.0021	0.00852	CcSEcCtD
Vildagliptin—Infestation NOS—Doxorubicin—muscle cancer	0.0021	0.00852	CcSEcCtD
Vildagliptin—Urticaria—Etoposide—muscle cancer	0.00205	0.00833	CcSEcCtD
Vildagliptin—Headache—Vincristine—muscle cancer	0.00199	0.0081	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00198	0.00806	CcSEcCtD
Vildagliptin—Angiopathy—Methotrexate—muscle cancer	0.00197	0.00802	CcSEcCtD
Vildagliptin—Chills—Methotrexate—muscle cancer	0.00195	0.00793	CcSEcCtD
Vildagliptin—Malnutrition—Methotrexate—muscle cancer	0.00189	0.00769	CcSEcCtD
Vildagliptin—Nausea—Vincristine—muscle cancer	0.00189	0.00768	CcSEcCtD
Vildagliptin—Hepatitis—Doxorubicin—muscle cancer	0.00188	0.00765	CcSEcCtD
Vildagliptin—Oedema peripheral—Doxorubicin—muscle cancer	0.00185	0.00754	CcSEcCtD
Vildagliptin—Asthenia—Etoposide—muscle cancer	0.00185	0.00752	CcSEcCtD
Vildagliptin—Connective tissue disorder—Doxorubicin—muscle cancer	0.00185	0.00752	CcSEcCtD
Vildagliptin—Diarrhoea—Etoposide—muscle cancer	0.00176	0.00717	CcSEcCtD
Vildagliptin—Angiopathy—Doxorubicin—muscle cancer	0.00171	0.00694	CcSEcCtD
Vildagliptin—Dizziness—Etoposide—muscle cancer	0.0017	0.00693	CcSEcCtD
Vildagliptin—Chills—Doxorubicin—muscle cancer	0.00169	0.00686	CcSEcCtD
Vildagliptin—Malnutrition—Doxorubicin—muscle cancer	0.00164	0.00666	CcSEcCtD
Vildagliptin—Headache—Etoposide—muscle cancer	0.00161	0.00657	CcSEcCtD
Vildagliptin—Flatulence—Doxorubicin—muscle cancer	0.00161	0.00656	CcSEcCtD
Vildagliptin—Arthralgia—Methotrexate—muscle cancer	0.00161	0.00655	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.0016	0.0065	CcSEcCtD
Vildagliptin—Infection—Methotrexate—muscle cancer	0.00153	0.00624	CcSEcCtD
Vildagliptin—Nausea—Etoposide—muscle cancer	0.00153	0.00623	CcSEcCtD
Vildagliptin—Nervous system disorder—Methotrexate—muscle cancer	0.00151	0.00616	CcSEcCtD
Vildagliptin—Skin disorder—Methotrexate—muscle cancer	0.0015	0.0061	CcSEcCtD
Vildagliptin—Hyperhidrosis—Methotrexate—muscle cancer	0.00149	0.00607	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00141	0.00572	CcSEcCtD
Vildagliptin—Arthralgia—Doxorubicin—muscle cancer	0.00139	0.00567	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00139	0.00563	CcSEcCtD
Vildagliptin—Oedema—Doxorubicin—muscle cancer	0.00134	0.00544	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00133	0.00542	CcSEcCtD
Vildagliptin—Fatigue—Methotrexate—muscle cancer	0.00133	0.00541	CcSEcCtD
Vildagliptin—Infection—Doxorubicin—muscle cancer	0.00133	0.0054	CcSEcCtD
Vildagliptin—Nervous system disorder—Doxorubicin—muscle cancer	0.00131	0.00533	CcSEcCtD
Vildagliptin—Skin disorder—Doxorubicin—muscle cancer	0.0013	0.00528	CcSEcCtD
Vildagliptin—Hyperhidrosis—Doxorubicin—muscle cancer	0.00129	0.00525	CcSEcCtD
Vildagliptin—Urticaria—Methotrexate—muscle cancer	0.00123	0.00499	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00122	0.00495	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00115	0.00469	CcSEcCtD
Vildagliptin—Fatigue—Doxorubicin—muscle cancer	0.00115	0.00469	CcSEcCtD
Vildagliptin—Constipation—Doxorubicin—muscle cancer	0.00114	0.00465	CcSEcCtD
Vildagliptin—Asthenia—Methotrexate—muscle cancer	0.00111	0.0045	CcSEcCtD
Vildagliptin—Urticaria—Doxorubicin—muscle cancer	0.00106	0.00432	CcSEcCtD
Vildagliptin—Diarrhoea—Methotrexate—muscle cancer	0.00106	0.0043	CcSEcCtD
Vildagliptin—Dizziness—Methotrexate—muscle cancer	0.00102	0.00415	CcSEcCtD
Vildagliptin—Headache—Methotrexate—muscle cancer	0.000967	0.00393	CcSEcCtD
Vildagliptin—Asthenia—Doxorubicin—muscle cancer	0.000959	0.0039	CcSEcCtD
Vildagliptin—Nausea—Methotrexate—muscle cancer	0.000917	0.00373	CcSEcCtD
Vildagliptin—Diarrhoea—Doxorubicin—muscle cancer	0.000915	0.00372	CcSEcCtD
Vildagliptin—Dizziness—Doxorubicin—muscle cancer	0.000884	0.00359	CcSEcCtD
Vildagliptin—Headache—Doxorubicin—muscle cancer	0.000838	0.00341	CcSEcCtD
Vildagliptin—Nausea—Doxorubicin—muscle cancer	0.000794	0.00323	CcSEcCtD
